CClinicalTrials.gg
CompletedNCT04840329Updated Feb 21, 2023

Endocation: Trial of an Endometriosis Education Program

An interventional study of Education in Endometriosis, sponsored by BC Women's Hospital & Health Centre. Completed at 1 site in Canada. Per ClinicalTrials.gov, last updated 2023-02-21.

Sponsored by BC Women's Hospital & Health Centre · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
67
Allocation
Randomized
Sex
All
01

Study summary

Endometriosis is a common condition that affects 10% of females, causing chronic pain and other health concerns. Currently, it takes 8-12 years to be diagnosed with endometriosis, in part because there is low awareness of this condition. This research is designed to test whether providing endometriosis education in schools can help increase early awareness of the condition.

02

Conditions studied

  • Endometriosis

Browse trials for

03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 8-12 grade level class

Exclusion criteria

Exclusion Criteria:

  • Instruction offered in a language other than English
04

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
67 participants (actual)

Study arms

  • Experimental
    Education Arm

    Behavioral: Education

  • No intervention
    Waitlist Control Arm

Interventions

  • BehavioralEducation

    One-time educational session about menstrual health and endometriosis

05

What researchers measure

Primary outcomes

  1. Change from baseline in menstrual health and endometriosis knowledge

    Assessed using a built for purpose questionnaire, possible scores range from 0 to 8

    Time frame: Baseline and 4 weeks

Secondary outcomes

  1. Change from baseline in prioritization of menstrual health

    Assessed using a built for purpose item, possible scores range from 0 to 4

    Time frame: Baseline and 4 weeks

  2. Change from baseline in confidence in endometriosis knowledge

    Assessed using a built for purpose item, possible scores range from 0 to 4

    Time frame: Baseline and 4 weeks

  3. Change from baseline in comfort with menstrual health

    Assessed using a built for purpose item, possible scores range from 0 to 4

    Time frame: Baseline and 4 weeks

  4. Acceptability of menstrual health and endometriosis education (quantitative)

    Assessed using a built for purpose questionnaire, possible scores range from 0 to 35

    Time frame: Immediately following education in intervention and waitlist control group

  5. Acceptability of menstrual health and endometriosis education (qualitative)

    Assessed using open-ended responses a built for purpose questionnaire

    Time frame: Immediately following education in intervention and waitlist control group

  6. Refusal of participants invited to participate

    Number of participants who refuse to participate divided by the number of participants invited to participate

    Time frame: Baseline

  7. Retention of participants

    Number of participants completing the study divided by the number of participants enrolled

    Time frame: 4 weeks

06

Study locations

1 site
  • BC Women's Hospital
    Vancouver, British Columbia V6H 3N1, Canada
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT04840329
Lead sponsor
BC Women's Hospital & Health Centre
Collaborators
BC Support Unit
Responsible party
Paul Yong (Associate Professor, BC Women's Hospital & Health Centre) — Principal investigator
First posted
Apr 12, 2021
Start date
Apr 9, 2021
Primary completion
May 20, 2021
Completion
May 20, 2021
Last update
Feb 21, 2023

Study contacts

Paul Yong
principal investigator · University of British Columbia

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion